News Coverage 11.06.19 Share on Twitter Share on Facebook Share on LinkedIn Early Results from First-In-U.S. Trial of CRISPR-Edited Immune Cells for Cancer Patients Suggest Safety of Approach Related Announcement, From Bench to Fireside Dr. Elizabeth Mittendorf on breast cancer breakthroughs Announcement, From Bench to Fireside PICI’s From Bench to Fireside Podcast Returns Announcement PICI 2024: Collaborative Breakthroughs in Cancer Immunotherapy